Rezolute Inc. (RZLT)
4.25
0.00 (0.00%)
Upcoming Events
Latest Headlines
FDA continues review of Rezolute's congenital HI drug data
September 9, 2026 7:00 AM - StreetInsider
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
September 9, 2026 7:00 AM - StreetInsider
Rezolute to Participate in Upcoming Investor Conferences
September 2, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
August 14, 2026 6:14 AM - SEC Filing
Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BANK OF AMERICA CORP /DE/
August 12, 2026 12:27 PM - SEC Filing
Form SCHEDULE 13G Rezolute, Inc. Filed by: Dellora Investments LP
August 12, 2026 11:05 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
July 30, 2026 6:53 AM - StreetInsider
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 21, 2026 7:30 AM - StreetInsider
Form 4 Rezolute, Inc. For: Jul 02 Filed by: ROBERTS BRIAN KENNETH
July 7, 2026 6:36 PM - SEC Filing
Form 4 Rezolute, Inc. For: Jul 02 Filed by: Elam Nevan C
July 7, 2026 5:27 PM - SEC Filing
Form 4 Rezolute, Inc. For: Jul 02 Filed by: Evans Daron
July 7, 2026 5:26 PM - SEC Filing
Rezolute presents hyperinsulinism data at Endocrine Society meeting
June 17, 2026 7:03 AM - StreetInsider
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
June 17, 2026 7:00 AM - StreetInsider
Full Article List
